Lab
Mercy Diagnostics INC
Mercy Diagnostics INC was paid $1.72M by Medicaid between Jan 2018 and Apr 2019, across 193 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 8.3% of everything it billed.
33Billing provider infoMERCY DIAGNOSTICS INC
MOUNT LAUREL, NJ 08054
MOUNT LAUREL, NJ 08054
33aNPI1043565021assigned 07/17/2012
33bProvider typeClinical Medical Laboratory
28Total paid$1.72M
24GClaims264,792
24DCodes billed193
24AFirst – last monthJan 2018 – Apr 2019
Compared with peers
Next to other Clinical Medical Laboratory providers in New Jersey
Rank by total paid#56 of 122
Median peer was paid$1.29M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 211,478 | $1.42M | |
| 2019 | 53,314 | $301K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 8.3% | 10,974 | 7,997 | $143K |
| 84443 | Thyroid stimulating hormone (TSH) | 7.0% | 14,562 | 10,731 | $121K |
| 80061 | Lipid panel | 6.5% | 13,197 | 10,968 | $112K |
| 80053 | Comprehensive metabolic panel | 5.3% | 16,607 | 12,962 | $91K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 4.8% | 616 | 320 | $83K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.4% | 6,493 | 4,389 | $76K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.4% | 6,427 | 4,357 | $75K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 18,466 | 13,542 | $65K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3.6% | 1,329 | 564 | $62K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.2% | 9,980 | 8,309 | $55K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.2% | 2,113 | 1,223 | $54K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.5% | 3,257 | 2,359 | $44K |
181 more codes
| 82607 | 2.3% | 4,981 | $40K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.9% | 2,718 | $33K |
| 84439 | 1.7% | 6,514 | $30K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.6% | 7,393 | $27K |
| 84481 | 1.5% | 4,031 | $27K | |
| 86803 | 1.5% | 3,605 | $26K | |
| 82746 | 1.0% | 2,649 | $18K | |
| 87070 | 1.0% | 2,964 | $17K | |
| 85027 | <1% | 4,557 | $17K | |
| 84153 | <1% | 1,221 | $15K | |
| 82728 | <1% | 3,153 | $15K | |
| 84403 | <1% | 1,295 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,317 | $14K |
| 87340 | <1% | 2,760 | $14K | |
| 87806 | <1% | 1,114 | $13K | |
| 86003 | <1% | 10,531 | $13K | |
| 86696 | <1% | 1,326 | $12K | |
| 87186 | <1% | 2,323 | $11K | |
| 86617 | <1% | 990 | $11K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,737 | $11K |
| 87481 | <1% | 1,022 | $11K | |
| 87653 | <1% | 1,143 | $10K | |
| 87511 | <1% | 906 | $10K | |
| 83540 | <1% | 3,881 | $9K | |
| 83550 | <1% | 2,692 | $9K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 1,134 | $9K |
| 86618 | <1% | 948 | $9K | |
| 86480 | <1% | 185 | $8K | |
| 87529 | <1% | 345 | $8K | |
| 81003 | <1% | 7,928 | $8K | |
| 80348 | <1% | 350 | $8K | |
| 86762 | <1% | 1,210 | $8K | |
| 83021 | <1% | 1,020 | $8K | |
| 84270 | <1% | 869 | $7K | |
| 86787 | <1% | 779 | $7K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 1,025 | $7K |
| 86706 | <1% | 939 | $7K | |
| 86695 | <1% | 978 | $6K | |
| 84480 | <1% | 885 | $6K | |
| 86038 | <1% | 1,064 | $6K | |
| 86592 | <1% | 3,126 | $6K | |
| 84146 | <1% | 542 | $5K | |
| 83001 | <1% | 615 | $5K | |
| 80050 | General health panel | <1% | 185 | $5K |
| 86666 | <1% | 783 | $5K | |
| 84702 | <1% | 1,509 | $4K | |
| 87522 | Neg quan hep c or qual rna | <1% | 222 | $4K |
| 86780 | <1% | 467 | $4K | |
| 86256 | <1% | 881 | $4K | |
| 83735 | <1% | 1,470 | $4K | |
| 86735 | <1% | 365 | $4K | |
| 87081 | <1% | 2,947 | $4K | |
| 86765 | <1% | 385 | $4K | |
| 83002 | <1% | 486 | $4K | |
| 86376 | <1% | 1,243 | $4K | |
| 83655 | <1% | 1,445 | $4K | |
| 82670 | <1% | 419 | $4K | |
| 82652 | <1% | 270 | $4K | |
| 82248 | <1% | 889 | $3K | |
| 86705 | <1% | 383 | $3K | |
| 86850 | <1% | 914 | $3K | |
| 86709 | <1% | 387 | $3K | |
| 86800 | <1% | 1,072 | $3K | |
| 86665 | <1% | 953 | $3K | |
| 82043 | <1% | 916 | $3K | |
| 84436 | <1% | 1,282 | $3K | |
| 86694 | <1% | 328 | $3K | |
| 84144 | <1% | 590 | $3K | |
| 82627 | <1% | 548 | $3K | |
| 82570 | <1% | 1,037 | $3K | |
| 86708 | <1% | 332 | $3K | |
| 87147 | <1% | 448 | $3K | |
| 83690 | <1% | 662 | $2K | |
| 81025 | <1% | 786 | $2K | |
| 86431 | <1% | 738 | $2K | |
| 83516 | <1% | 781 | $2K | |
| 83525 | <1% | 516 | $2K | |
| 84550 | <1% | 1,026 | $2K | |
| 82465 | <1% | 1,549 | $2K | |
| 86140 | <1% | 1,096 | $2K | |
| 87088 | <1% | 689 | $2K | |
| 80076 | <1% | 583 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 104 | $2K |
| 87480 | <1% | 262 | $2K | |
| 86704 | <1% | 261 | $2K | |
| 83013 | <1% | 61 | $2K | |
| 82150 | <1% | 538 | $2K | |
| 82950 | <1% | 993 | $2K | |
| 81511 | <1% | 490 | $2K | |
| 87510 | <1% | 262 | $2K | |
| 84207 | <1% | 106 | $2K | |
| 82533 | <1% | 756 | $2K | |
| 83970 | <1% | 58 | $2K | |
| 82550 | <1% | 561 | $2K | |
| 87660 | <1% | 262 | $2K | |
| 85652 | <1% | 1,403 | $2K | |
| 87205 | <1% | 590 | $1K | |
| 84154 | <1% | 119 | $1K | |
| 86664 | <1% | 474 | $1K | |
| 86141 | <1% | 578 | $1K | |
| 85610 | <1% | 631 | $1K | |
| 80055 | <1% | 96 | $1K | |
| 86663 | <1% | 481 | $1K | |
| 82785 | <1% | 157 | $1K | |
| 86901 | <1% | 1,173 | $1K | |
| 86900 | <1% | 1,171 | $1K | |
| 86611 | <1% | 285 | $987.40 | |
| 85651 | <1% | 686 | $976.09 | |
| 82947 | <1% | 600 | $974.73 | |
| 85730 | <1% | 320 | $950.51 | |
| 82105 | <1% | 212 | $935.91 | |
| 83718 | <1% | 653 | $873.89 | |
| 82784 | <1% | 288 | $837.71 | |
| 87077 | <1% | 150 | $770.91 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 512 | $742.02 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 72 | $664.10 |
| 84100 | <1% | 275 | $650.71 | |
| 82951 | <1% | 106 | $599.30 | |
| 80081 | <1% | 58 | $591.50 | |
| 84703 | <1% | 123 | $524.10 | |
| 86200 | <1% | 50 | $492.88 | |
| 81015 | <1% | 4,075 | $490.77 | |
| 84450 | <1% | 206 | $423.58 | |
| 83090 | <1% | 266 | $395.61 | |
| 80349 | <1% | 80 | $362.29 | |
| 80360 | <1% | 131 | $349.70 | |
| 81001 | <1% | 177 | $334.58 | |
| 86039 | <1% | 82 | $333.08 | |
| 85018 | <1% | 338 | $292.04 | |
| 83880 | <1% | 12 | $279.12 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 33 | $270.99 |
| 84460 | <1% | 179 | $261.40 | |
| 82565 | <1% | 175 | $255.22 | |
| 87045 | <1% | 111 | $253.53 | |
| 84482 | <1% | 327 | $237.20 | |
| 87254 | <1% | 24 | $227.45 | |
| 84630 | <1% | 475 | $217.26 | |
| 86060 | <1% | 99 | $192.52 | |
| 82952 | <1% | 102 | $186.15 | |
| 82977 | <1% | 137 | $180.07 | |
| 86317 | <1% | 14 | $146.56 | |
| 82671 | <1% | 13 | $123.40 | |
| 86308 | <1% | 39 | $114.19 | |
| 82626 | <1% | 14 | $111.34 | |
| 83615 | <1% | 42 | $100.52 | |
| 84520 | <1% | 109 | $96.36 | |
| 87209 | <1% | 21 | $95.67 | |
| 84155 | <1% | 121 | $94.89 | |
| 86738 | <1% | 12 | $94.82 | |
| 81291 | <1% | 43 | $94.53 | |
| 82525 | <1% | 327 | $78.87 | |
| 80359 | <1% | 102 | $62.55 | |
| 80324 | <1% | 102 | $62.55 | |
| 87625 | <1% | 235 | $61.96 | |
| 87623 | <1% | 231 | $61.96 | |
| 82274 | <1% | 30 | $53.70 | |
| 81508 | <1% | 153 | $41.54 | |
| 84140 | <1% | 25 | $41.06 | |
| 86645 | <1% | 16 | $40.01 | |
| 87177 | <1% | 21 | $38.72 | |
| 82310 | <1% | 19 | $34.22 | |
| 85007 | <1% | 116 | $31.15 | |
| 86644 | <1% | 16 | $22.95 | |
| 82390 | <1% | 132 | $16.82 | |
| 80321 | <1% | 144 | $12.51 | |
| 80369 | 0% | 143 | $0.00 | |
| 80366 | 0% | 367 | $0.00 | |
| 80323 | 0% | 144 | $0.00 | |
| 80373 | 0% | 145 | $0.00 | |
| 80337 | 0% | 368 | $0.00 | |
| 80355 | 0% | 368 | $0.00 | |
| 80354 | 0% | 143 | $0.00 | |
| 80372 | 0% | 145 | $0.00 | |
| 80365 | 0% | 58 | $0.00 | |
| 80346 | 0% | 40 | $0.00 | |
| 80361 | 0% | 59 | $0.00 | |
| 99000 | 0% | 71 | $0.00 | |
| 83088 | 0% | 71 | $0.00 | |
| 80368 | 0% | 143 | $0.00 | |
| 80353 | 0% | 35 | $0.00 | |
| 86356 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIS, MIKE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Health Care Plus, INC | Knoxville, TN | $359K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.